IcilmaVFergusMD

Interventional Cardiology

Associate Professor, Medicine, Mount Sinai School of Medicine

Dr. Fergus is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1 Gustave L Levy Pl
Ste 29903
New York, NY 10029
Phone+1 212-241-3271

Fax+1 212-348-7908

New York Presbyterian Hospital(Cornell Campus)/Coney Island HospitalFellowship, Cardiovascular Disease, 1996 - 1999
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1992 - 1995
State University of New York Downstate Medical Center College of MedicineClass of 1992

PubMed

6 citations
Rationale and Design of the SOTA-P-CARDIA Trial (ATRU-V): Sotagliflozin in HFpEF Patients Without Diabetes.
Maeve Soto Pérez, Jorge Rodríguez-Capitán, Juan Antonio Requena-Ibáñez, Carlos G Santos-Gallego, M Urooj Zafar
Cardiovascular Drugs and Therapy. 2023-06-15
5 citations
Bioprosthetic Valve Thrombosis Associated with COVID-19 Infection.
Steven A. Alexander, Icilma V. Fergus, Stamatios Lerakis
Circulation. Cardiovascular Imaging. 2021-02-05
278 citations
Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction.
Carlos G. Santos-Gallego, Ariana P. Vargas-Delgado, Juan Antonio Requena-Ibanez, Alvaro Garcia-Ropero, Donna M. Mancini
Journal of the American College of Cardiology. 2021-01-26

The Intersection of Heart Disease, Diabetes and StrokeAugust 20th, 2024
Female Cardiologists Share 9 Things Women Should Never Do to Protect Their Heart HealthFebruary 8th, 2023
Heart Medications Can Be a Huge Financial Strain, but the Reconciliation Bill Could HelpAugust 5th, 2022
Join now to see all